Pfizer Inc (PFE)

Pfizer Inc. is a healthcare company listed on the NYSE as common stock under the ticker PFE. The company develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and abroad. Its operations are organized into three segments: Biopharma, PC1, and Pfizer Ignite. Pfizer’s portfolio spans internal medicine, including cardiovascular and metabolic therapies such as Eliquis; migraine treatments including Nurtec ODT/Vydura and Zavzpret; vaccines such as the Prevnar family, Abrysvo, Nimenrix, FSME-IMMUN/TicoVac, and Trumenba; and Paxlovid for COVID-19. It also markets medicines in inflammation and immunology, rare disease, anti-infectives, immunoglobulins, oncology, biosimilars, and sterile injectables. The company maintains collaboration agreements with Bristol-Myers Squibb, Astellas Pharma US, Merck KGaA, and BioNTech, and it also has a strategic collaboration with Boltz, PBC focused on biomolecular AI foundation models. Pfizer was founded in 1849 and is headquartered in New York, New York.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.